IMPACT [gngm]
Prolonged [tmco]
Cyclo-Oxygenase II [aapp, enzy]
Inhibition [menp]
Inflammatory [ftcn]
Marker [clna]
Endothelial [tisu]
function [phsf]
Patients [podg]
ischaemic heart disease [dsyn]
Raised C-reactive protein [fndg]
randomized [resa]
placebo controlled study [inpr, resa]
IMPACT [gngm]
Cyclo-Oxygenase II [aapp, enzy]
Antagonist [ortf]
treatment [ftcn]
acute [tmco]
coronary [bpoc]
controversies [socb]
investigated [ftcn]
Prolonged [tmco]
COX-2 [aapp, enzy]
Inhibition [menp]
Inflammatory [ftcn]
Profile [lbpr]
Endothelial [tisu]
function [phsf]
Patients [podg]
ischaemic heart disease [dsyn]
C-reactive protein [aapp, imft]
Values [qlco]
Methods [inpr]
Double-Blind Study [resa]
Stable [qlco]
Subject [grup]
Low-Dose Aspirin [orch, phsu]
Equal [qlco]
Previous [tmco]
acute [tmco]
coronary [bpoc]
Events [evnt]
Screening [hlca]
C-reactive protein [aapp, imft]
Values [qlco]
mg/L [qnco]
randomized [resa]
COX2 inhibitor [orch, phsu]
rofecoxib [orch, phsu]
mg% [qnco]
placebo [topp]
Daily [tmco]
months [tmco]
C-reactive protein [aapp, imft]
Interleukin-6 [aapp, imft]
P-Selectin [aapp, imft]
Matrix Metalloproteinase 9 [aapp, enzy]
Brachial Artery [bpoc]
Endothelial [tisu]
function [phsf]
Evaluated [ftcn]
placebo [topp]
Group [idcn]
C-reactive protein [aapp, imft]
mg/L [qnco]
Quartile [qlco]
>90 [qnco]
.5 L [qnco]
mg% [qnco]
baseline [bodm]
mg/L [qnco]
Quartile [qlco]
mg/L [qnco]
months [tmco]
rofecoxib [orch, phsu]
Group [idcn]
C-reactive protein [aapp, imft]
mg/L [qnco]
Quartile [qlco]
.5 L [qnco]
mg% [qnco]
baseline [bodm]
mg/L [qnco]
Quartile [qlco]
mg/L [qnco]
months [tmco]
P NOS [aapp, imft]
rofecoxib [orch, phsu]
Compared [acty]
placebo [topp]
lowered [spco]
Interleukin-6 [aapp, imft]
months [tmco]
P NOS [aapp, imft]
Drug effect [ftcn]
C-reactive protein [aapp, imft]
Interleukin-6 [aapp, imft]
rofecoxib [orch, phsu]
Group 3 [inpr]
months [tmco]
treatment [ftcn]
P NOS [aapp, imft]
P NOS [aapp, imft]
rofecoxib [orch, phsu]
Affect [menp]
P-Selectin [aapp, imft]
Matrix Metalloproteinase 9 [aapp, enzy]
Brachial Artery [bpoc]
Conclusions [idcn]
Prolonged [tmco]
COX-2 [aapp, enzy]
Inhibition [menp]
Attenuate [acty]
C-reactive protein [aapp, imft]
Interleukin-6 [aapp, imft]
MODIFY [ftcn]
P-Selectin [aapp, imft]
Matrix Metalloproteinase 9 [aapp, enzy]
Endothelial [tisu]
function [phsf]
Stable [qlco]
Patients [podg]
History [ocdi]
Recurrent acute [tmco]
coronary [bpoc]
Events [evnt]
Raised C-reactive protein [fndg]
Rationale [idcn]
Evaluate [ftcn]
Benefit [qnco]
COX-2 [aapp, enzy]
Inhibition [menp]
Patients [podg]
ischaemic heart disease [dsyn]
